APOL1 toxin, innate immunity, and kidney injury

Sophie Limou1, Patrick D Dummer2, George W Nelson3

  • 1Molecular Genetic Epidemiology Section, Basic Research Laboratory, Basic Science Program, Center for Cancer Research, NCI, NIH, Leidos Biomedical Research, Frederick National Laboratory, Frederick, Maryland, USA.

Kidney International
|April 9, 2015
PubMed

Insights

Apolipoprotein L 1 (APOL1) gene variants are linked to kidney disease in people of African descent. This review explores APOL1

Area of Science:

  • Nephrology and Genetics
  • Molecular and Cellular Biology

Background:

  • Two common APOL1 alleles are strongly associated with nondiabetic kidney diseases in African descent populations.
  • The precise biological function of APOL1 in kidney cells and the pathogenic mechanisms of renal risk alleles remain unclear.
  • Understanding APOL1 function is crucial for developing targeted diagnostics and therapeutics for kidney diseases.

Purpose of the Study:

  • To review the current understanding of APOL1 biological functions, including its role in trypanosome resistance and intracellular processes like autophagy.
  • To present a novel multimer model for APOL1 in kidney cells.
  • To reconcile gain-of-function variants with the recessive inheritance pattern of APOL1 renal risk alleles.

Main Methods:

  • Literature review synthesizing findings on APOL1's defense mechanisms against trypanosomes.
  • Analysis of emerging roles for intracellular APOL1, particularly in autophagy.
  • Development and presentation of a theoretical multimer model for APOL1 function in kidney cells.

Main Results:

  • APOL1 exhibits dual functions: circulating APOL1 confers resistance to trypanosome infections.
  • Intracellular APOL1 is implicated in cellular processes, with an emerging role in autophagy.
  • A proposed multimer model explains how gain-of-function variants align with recessive inheritance of APOL1-associated kidney disease.

Conclusions:

  • APOL1's complex functions in both extracellular and intracellular environments are key to understanding its role in kidney disease.
  • The multimer model offers a framework for understanding the pathogenicity of APOL1 risk variants.
  • Further research into APOL1's cellular mechanisms is essential for clinical advancements in nephropathy treatment.

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
2.0K
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.3K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
518
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.6K
Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma...
9.6K
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.1K